JP2004500317A5 - - Google Patents

Download PDF

Info

Publication number
JP2004500317A5
JP2004500317A5 JP2000565858A JP2000565858A JP2004500317A5 JP 2004500317 A5 JP2004500317 A5 JP 2004500317A5 JP 2000565858 A JP2000565858 A JP 2000565858A JP 2000565858 A JP2000565858 A JP 2000565858A JP 2004500317 A5 JP2004500317 A5 JP 2004500317A5
Authority
JP
Japan
Prior art keywords
tablets
amount
water
tablet
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000565858A
Other languages
English (en)
Japanese (ja)
Other versions
JP5411398B2 (ja
JP2004500317A (ja
Filing date
Publication date
Priority claimed from US09/379,310 external-priority patent/US6248358B1/en
Application filed filed Critical
Publication of JP2004500317A publication Critical patent/JP2004500317A/ja
Publication of JP2004500317A5 publication Critical patent/JP2004500317A5/ja
Application granted granted Critical
Publication of JP5411398B2 publication Critical patent/JP5411398B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000565858A 1998-08-25 1999-08-24 長時間放出性の口腔生物接着性錠剤 Expired - Fee Related JP5411398B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9784398P 1998-08-25 1998-08-25
US60/097,843 1998-08-25
US09/379,310 US6248358B1 (en) 1998-08-25 1999-08-23 Bioadhesive progressive hydration tablets and methods of making and using the same
US09/379,310 1999-08-23
PCT/US1999/019260 WO2000010536A1 (en) 1998-08-25 1999-08-24 Extended release buccal bioadhesive tablet

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010151682A Division JP2010248231A (ja) 1998-08-25 2010-07-02 長時間放出性の口腔生物接着性錠剤

Publications (3)

Publication Number Publication Date
JP2004500317A JP2004500317A (ja) 2004-01-08
JP2004500317A5 true JP2004500317A5 (cg-RX-API-DMAC7.html) 2013-03-28
JP5411398B2 JP5411398B2 (ja) 2014-02-12

Family

ID=22265404

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000565858A Expired - Fee Related JP5411398B2 (ja) 1998-08-25 1999-08-24 長時間放出性の口腔生物接着性錠剤
JP2010151682A Pending JP2010248231A (ja) 1998-08-25 2010-07-02 長時間放出性の口腔生物接着性錠剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010151682A Pending JP2010248231A (ja) 1998-08-25 2010-07-02 長時間放出性の口腔生物接着性錠剤

Country Status (25)

Country Link
US (1) US6248358B1 (cg-RX-API-DMAC7.html)
EP (1) EP1105104B1 (cg-RX-API-DMAC7.html)
JP (2) JP5411398B2 (cg-RX-API-DMAC7.html)
KR (1) KR100716702B1 (cg-RX-API-DMAC7.html)
CN (2) CN1259903C (cg-RX-API-DMAC7.html)
AR (1) AR036972A1 (cg-RX-API-DMAC7.html)
AT (1) ATE306253T1 (cg-RX-API-DMAC7.html)
AU (1) AU754880B2 (cg-RX-API-DMAC7.html)
BR (1) BR9913239B1 (cg-RX-API-DMAC7.html)
CA (1) CA2341375C (cg-RX-API-DMAC7.html)
DE (1) DE69927694T2 (cg-RX-API-DMAC7.html)
DK (1) DK1105104T3 (cg-RX-API-DMAC7.html)
ES (1) ES2251220T3 (cg-RX-API-DMAC7.html)
HU (1) HU226591B1 (cg-RX-API-DMAC7.html)
IL (1) IL141445A (cg-RX-API-DMAC7.html)
MA (1) MA24964A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA01002007A (cg-RX-API-DMAC7.html)
MY (2) MY125919A (cg-RX-API-DMAC7.html)
NO (1) NO331255B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ509963A (cg-RX-API-DMAC7.html)
PE (1) PE20001036A1 (cg-RX-API-DMAC7.html)
RU (1) RU2227022C2 (cg-RX-API-DMAC7.html)
UA (1) UA78967C2 (cg-RX-API-DMAC7.html)
WO (1) WO2000010536A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA995445B (cg-RX-API-DMAC7.html)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6624200B2 (en) * 1998-08-25 2003-09-23 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
AU2005203703B2 (en) * 1998-08-25 2007-05-24 Columbia Laboratories (Bermuda) Limited Bioadhesive progressive hydration tablets
US7803392B2 (en) 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
WO2002087552A2 (en) * 2001-05-01 2002-11-07 Mcgill University Androgen-mediated neuroprotection and uses thereof
US7709026B2 (en) 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) * 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
CN1684667A (zh) * 2002-08-02 2005-10-19 兰贝克赛实验室有限公司 贮藏稳定的福辛普利钠片剂
RU2213558C1 (ru) * 2002-09-30 2003-10-10 Нестерук Владимир Викторович Антибактериальное средство
US20040127476A1 (en) * 2002-11-14 2004-07-01 Alvin Kershman Oral testosterone delivery system with improved sustained release
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
JP5283334B2 (ja) * 2003-01-24 2013-09-04 マグル ホールディング エービー 経粘膜伝達用組成物材料
WO2005118166A2 (en) 2004-06-04 2005-12-15 Teva Pharmaceutical Industries, Ltd. Pharmaceutical composition containing irbesartan
ME01316B (me) * 2004-08-13 2013-12-20 Boehringer Ingelheim Int Formulacija tablete sa produženim oslobađanjem koji sadrži pramipeksol ili njegovu farmaceutski prihvatljivu so
UA88477C2 (ru) * 2004-08-13 2009-10-26 Бёрингер Ингельхайм Интернациональ Гмбх Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
WO2006133048A2 (en) * 2005-06-03 2006-12-14 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same
US20070048369A1 (en) * 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
US9522188B2 (en) 2005-12-13 2016-12-20 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
US20090098202A1 (en) * 2006-02-10 2009-04-16 Boehringer Ingelheim International Gmbh Extended Release Formulation
US20090041844A1 (en) * 2006-02-10 2009-02-12 Boehringer Ingelheim International Gmbh Modified Release Formulation
WO2007096906A2 (en) * 2006-02-27 2007-08-30 Panacea Biotec Ltd. Novel buccoadhesive compositions and process of preparation thereof
EP1837020A1 (en) 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
US20070248655A1 (en) * 2006-04-21 2007-10-25 Haley Jeffrey T Lenticular shaped protective mouth sore discs
EP1872775A1 (en) * 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
ES2577390T3 (es) 2006-07-21 2016-07-14 Biodelivery Sciences International, Inc. Dispositivos de administración transmucosa con mayor captación
EP2112923A1 (en) 2007-01-22 2009-11-04 Targacept Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
US8889632B2 (en) 2007-01-31 2014-11-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
EP2508531B1 (en) 2007-03-28 2016-10-19 President and Fellows of Harvard College Stitched polypeptides
EP1987820A1 (en) * 2007-05-04 2008-11-05 Christian Fiala, Ph. D. Slow release misoprostol for obstetric and/or gynaecological applications
US20090269403A1 (en) * 2008-04-24 2009-10-29 Shaked Ze Ev Oral contraceptive dosage forms and methods of making such dosage forms
EP2163240A1 (en) * 2008-09-12 2010-03-17 Universita' Degli Studi Di Genova A method for the production of bioadhesive compact matrices
CA2765221C (en) 2009-06-18 2017-10-03 Allergan, Inc. Safe desmopressin administration
SI2603600T1 (sl) 2010-08-13 2019-04-30 Aileron Therapeutics, Inc. Peptidomimetični makrocikli
MX352959B (es) 2011-08-18 2017-12-15 Biodelivery Sciences Int Inc Dispositivos mucoadhesivos resistentes al abuso para el suministro de buprenorfina.
TW201806968A (zh) 2011-10-18 2018-03-01 艾利倫治療公司 擬肽巨環化合物
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
KR102112373B1 (ko) 2012-02-15 2020-05-18 에일러론 테라퓨틱스 인코포레이티드 펩티드모방체 마크로사이클
HK1205454A1 (en) 2012-02-15 2015-12-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
WO2014071241A1 (en) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
BR112017005598A2 (pt) 2014-09-24 2017-12-12 Aileron Therapeutics Inc macrociclos peptidomiméticos e usos dos mesmos
WO2016154058A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
MA56011A (fr) * 2019-04-05 2022-04-06 Gedea Biotech Ab Formulation de comprimé vaginal

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133862A (en) 1960-07-22 1964-05-19 Miles Lab Buccal tablet containing vitamin a and sodium proteinate
GB2042888B (en) 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
CH653550A5 (de) * 1981-10-20 1986-01-15 Sandoz Ag Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
US4389393A (en) 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
CA1208558A (en) 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
JPH0830004B2 (ja) 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
US5225196A (en) * 1983-11-14 1993-07-06 Columbia Laboratories, Inc. Bioadhesive compositions and methods of treatment therewith
US4540566A (en) 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS60215622A (ja) * 1984-04-09 1985-10-29 Toyobo Co Ltd 口腔粘膜適用徐放性製剤
US4740365A (en) 1984-04-09 1988-04-26 Toyo Boseki Kabushiki Kaisha Sustained-release preparation applicable to mucous membrane in oral cavity
US4596795A (en) 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4764378A (en) 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
ES2039226T3 (es) 1986-12-30 1993-09-16 American Cyanamid Company Procedimiento para preparar composiciones que contienen policarbofil.
US4915948A (en) 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
US4900552A (en) 1988-03-30 1990-02-13 Watson Laboratories, Inc. Mucoadhesive buccal dosage forms
US5252334A (en) 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
US6017521A (en) * 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
WO1991006289A1 (en) * 1989-10-31 1991-05-16 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
US5750136A (en) 1989-11-03 1998-05-12 Riker Laboratories, Inc. Bioadhesive composition and patch
US5750134A (en) 1989-11-03 1998-05-12 Riker Laboratories, Inc. Bioadhesive composition and patch
EP0459373A3 (en) * 1990-05-31 1993-09-08 The B.F. Goodrich Company Bioadhesive carboxylic polymer composition and method relating thereto
FR2665357B1 (fr) 1990-07-31 1995-03-31 Aiache Jean Marc Procede de preparation d'une forme galenique bio-adhesive et forme galenique ainsi preparee.
US5686094A (en) 1991-04-01 1997-11-11 Theratech, Inc. Controlled release formulations for the treatment of xerostomia
US5110605A (en) 1990-08-21 1992-05-05 Oramed, Inc. Calcium polycarbophil-alginate controlled release composition and method
US5102666A (en) 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
JP2609022B2 (ja) 1990-11-29 1997-05-14 北陸製薬株式会社 ポリカルボフィルカルシウム含有製剤
JPH06100466A (ja) 1992-02-14 1994-04-12 Tsumura & Co ストレス性脳神経細胞器質障害防御剤
ATE155681T1 (de) 1992-05-18 1997-08-15 Minnesota Mining & Mfg Einrichtung zur transmucosalen wirkstoffabgabe
GR1002418B (el) * 1992-07-29 1996-08-21 Johnson & Johnson Consumer Products Inc. Βιοεπισυναπτομενες συνθεσεις θεραπειας και μεθοδοι χρησης.
US5458884A (en) 1992-09-10 1995-10-17 Britton; Peter Bioerodible device for administering active ingredients
FI933979A0 (fi) 1992-09-10 1993-09-10 Mcneil Ppc Inc Bioeroderbar anordning foer dosering av aktiva ingredienser
US5298017A (en) 1992-12-29 1994-03-29 Alza Corporation Layered electrotransport drug delivery system
US5460820B1 (en) 1993-08-03 1999-08-03 Theratech Inc Method for providing testosterone and optionally estrogen replacement therapy to women
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
FR2712807B1 (fr) 1993-11-24 1996-02-23 Vetoquinol Sa Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
US5578315A (en) * 1993-12-01 1996-11-26 Rutgers, The State University Of New Jersey Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
US5567439A (en) 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
AU692565B2 (en) 1994-06-16 1998-06-11 Pharmacia & Upjohn S.P.A. Bioadhesive starches and process for their preparation
US5554380A (en) 1994-08-04 1996-09-10 Kv Pharmaceutical Company Bioadhesive pharmaceutical delivery system
US5656284A (en) 1995-04-24 1997-08-12 Balkin; Michael S. Oral transmucosal delivery tablet and method of making it
US5624677A (en) 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US5766620A (en) 1995-10-23 1998-06-16 Theratech, Inc. Buccal delivery of glucagon-like insulinotropic peptides
RU2095064C1 (ru) * 1995-11-24 1997-11-10 Анатолий Борисович Давыдов Средство для снижения агрегации тромбоцитов в кровеносной системе
US5783212A (en) 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
DE19619045C1 (de) 1996-05-02 1997-11-13 Jenapharm Gmbh Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen
US5783208A (en) 1996-07-19 1998-07-21 Theratech, Inc. Transdermal drug delivery matrix for coadministering estradiol and another steroid
US5800832A (en) 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US5807575A (en) 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds

Similar Documents

Publication Publication Date Title
JP5411398B2 (ja) 長時間放出性の口腔生物接着性錠剤
Acarturk Mucoadhesive vaginal drug delivery systems
US6624200B2 (en) Bioadhesive progressive hydration tablets
RU2001107846A (ru) Биоадгезивная буккальная таблетка длительного выделения
US9084796B2 (en) Hormonal composition and its use
JP2010248232A (ja) 膣感染を処置又は予防するための低濃度のペルオキサイド
WO2013038402A1 (en) Vaginal danazol combined with non steroidal anti inflammatory drugs (nsaids) compositions
US6207696B1 (en) Compositions and methods for the prophylaxis and treatment of dysmenorrhea, endometriosis, and pre-term labor, using histidine
JPH09165344A (ja) 膣用固形医薬品組成物
AU2002346897A1 (en) Low concentration of peroxide for treating or preventing vaginal infections
US20060159751A1 (en) Controlled release pharmaceutical compositions of carbidopa and levodopa
AU780736B2 (en) Treating endometriosis or infertility, or improving fertility
WO2004017938A2 (en) Nitrofurantoin controlled release dosage form
CN112007006B (zh) 一种治疗口腔溃疡的药用组合物及其制备方法
JP4871258B2 (ja) トラセミドとマトリックス形成ポリマーとを含む持続放出型組成物(prolonged−release composition)
CN101152187A (zh) 依普利酮药物组合物
US12011423B2 (en) S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
TWI337084B (en) Pharmaceutical composition containing low concentration of peroxide for treating or preventing vaginal infections
WO2023051780A1 (zh) 一种口服药物组合物
TWI319987B (en) Bioadhesive progressive hydration tablets
KR20030043797A (ko) 호르몬 조성물
HK1034895B (en) Extended release buccal bioadhesive tablet
KR20050057349A (ko) 하부요로증상 치료를 위한 퀴나졸린 유도체의 용도